Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
This dynamic can trouble even the most skilled investors, but luckily for you, we started StockStory to help you navigate these trade-offs and uncover exceptional companies that break the mold. Keeping that in mind, here are two large-cap stocks with attractive long-term potential and one whose existing offerings may be tapped out.
One Large-Cap Stock to Sell:
CVS Health (CVS)
Market Cap: $137.1 billion
With over 9,000 retail pharmacy locations serving as neighborhood health destinations across America, CVS Health (NYSE: CVS) operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance through its Aetna subsidiary.
Why Do We Think Twice About CVS?
- The company has faced growth challenges as its 6.3% annual revenue increases over the last two years fell short of other healthcare companies
- Demand will likely fall over the next 12 months as Wall Street expects flat revenue
- Incremental sales over the last five years were much less profitable as its earnings per share fell by 1.5% annually while its revenue grew
CVS Health is trading at $107.70 per share, or 13.9x forward P/E. Read our free research report to see why you should think twice about including CVS in your portfolio.
Two Large-Cap Stocks to Buy:
Cloudflare (NET)
Market Cap: $98.55 billion
With a massive network spanning more than 310 cities in over 120 countries, Cloudflare (NYSE: NET) provides a global network that delivers security, performance and reliability services to protect websites, applications, and corporate networks.
What Makes NET Stand Out?
- Average billings growth of 34.2% over the last year enhances its liquidity and shows there is steady demand for its products
- Expected revenue growth of 28.4% for the next year suggests its market share will rise
- Fast payback periods on sales and marketing expenses allow the company to invest heavily and onboard many customers concurrently
At $276.18 per share, Cloudflare trades at 32.1x forward price-to-sales. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free.
Rocket Lab (RKLB)
Market Cap: $40.45 billion
Becoming the first private company in the Southern Hemisphere to reach space, Rocket Lab (NASDAQ: RKLB) offers rockets designed for launching small satellites.
Why Is RKLB a Good Business?
- Annual revenue growth of 55.1% over the last two years was superb and indicates its market share increased during this cycle
- Operating margin expanded by 111.4 percentage points over the last five years as it scaled and became more efficient
- Cash-burning tendencies have improved over the last five years, showing it could become financially independent one day
Rocket Lab’s stock price of $68.20 implies a valuation ratio of 41.3x forward price-to-sales. Is now a good time to buy? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.
